The Hypersensitivity and Dysmotility Group studied the effect of meals on sensory, motor and hedonic responses in patients with functional dyspepsia, and small bowel motility disorders and initiated studies on virtual therapies for patients with disorders of the brain-gut axis. The Inflammatory bowel disease Group studied the role of microbiota and the impact of biological therapy pharmacokinetics in these disorders. The group of pancreas has contributed to find indications on the role of microbiota-based screening for the early detection of pancreatic ductal adenocarcinoma and published guidelines on chronic pancreatitis. The Neuro-Immuno-Gastroenterology Group has developed a European Microscopic Colitis Activity Index and an intestinal gas questionnaire and performed studies on the role of colonic microbiota in microscopic colitis, on the eosinophil-neuron interaction, serotonin, COVID-19 and permeability in brain-gut disorders and on a registry of eosinophilic esophagitis

Group Leader
Fernando Azpiroz Vidaur

Principal Investigator (PI)
Carmen Alonso Cotoner, Natalia Borruel Sainz, Francesc Casellas Jorda, Danila Guagnozzi, Beatriz Lobo Alvarez, Carolina Malagelada Prats, Francesc Xavier Molero Richard, Francisco Javier Santos Vicente, Jorge Serra Pueyo, María Vicario Pérez

Researchers
Luís Alcalá González, Claudia Barber Casellas, Ana María González Castro, Blanca Grases Pintó, Claudia Herrera De Guise, Ronald Llerena Castro, Virginia Robles Alonso, Teodora Pribic, Francisca Yañez Araya, Encarna Varela Castro

PhD Students
Lara Aguilera Castro, Elena Cespedes Martinez, Luís Mayorga Ayala, Xavier Serra Ruiz, Stephanie Tasayco, Xavier Serra Ruíz, Ariadna Aguilar Cayuelas, Laura Campderros Traver, Mercé Albert Bayo

Lab Technicians
Laura Hui Perez Guerrero, Elba Expósito Fernández, Marta Far Serrano

Nursing and Technical Staff
Consuelo Cammarota, Laia Comas Fernández, Adoración Nieto Ruíz, Josefina Heredia Montiel, Gloria Santaliestra Vivaracho

41

PUBLICATIONS

34.1%

%Q1

252

IMPACT FACTOR

6.14

AVERAGE IMPACT FACTOR

SELECTED ARTICLES

Kartal E, Schmidt TSB, Molina-Montes E, Rodriguez-Perales S, Wirbel J, Maistrenko OM, Akanni WA, Alashkar Alhamwe B, Alves RJ, Carrato A, Erasmus HP, Estudillo L, Finkelmeier F, Fullam A, Glazek AM, Gomez-Rubio P, Hercog R, Jung F, Kandels S, Kersting S, Langheinrich M, Marquez M, Molero X, Orakov A, Van Rossum T, Torres-Ruiz R, Telzerow A, Zych K, Benes V, Zeller G, Trebicka J, Real FX, Malats N, Bork P, Malats N, Real FX, deMaturana EL, Gomez-Rubio P, Molina-Montes E, Alonso L, Marquez M, Milne R, Alfaro A, Lobato T, Estudillo L, Lawlor R, Scarpa A, Beghelli S, Sharp L, Hidalgo M, Rodriguez J, Carrato A, Caminoa A, Guillen-Ponce C, Rodriguez-Garrote M, Longo-Munoz F, Ferreiro R, Pachon V, Mar Iglesias LI, Alvarez-Urturi C, Bessa X, Bory F, Marquez L, Poves I, Burdio F, Grande L, Gimeno J, Molero X, Guarner L, Balcells J, Salcedo M, Michalski C, Esposito I, Kleeff J, Kong B, Lohr M, Huang J, Verbeke C, Ye W, Yu J, Perea J, Pelaez P, Farre A, Mora J, Martin M, Artigas V, Guarner C, JSancho F, yCajal TR, Greenhalf W, O'Rorke M, Murray L, Cantwell M, MBarbera V, Tardon A, Barneo L, Munoz ED, Lozano A, Luaces M, Munoz-Bellvis L, Sayagues Manzano JM, Gutierrrez Troncoso , deMatos A, Gress T, Buchholz M, Neesse A, Crnogorac-Jurcevic T, Kocher HM, Bhattacharya S, Tabraham A, Ennis D, Dowe T, Radon T, Silverman DT, Easton D, Hans-Peter JT, FabianFinkelmeier E, WenyiGuOlaf RS, Erhard T, Stefan U, Kersting S, Langheinrich M, Grutzmann R, FWeber G, Pilarsky C
A faecal microbiota signature with high specificity for pancreatic cancer
Gut. 2022 Jul;71(7):1359-1372.
DOI: doi: 10.1136/gutjnl-2021-324755.
IF: 31.80

Marasco G, Cremon C, Barbaro MR, Cacciari G, Falangone F, Kagramanova A, Bordin D, Drug V, Miftode E, Fusaroli P, Mohamed SY, Ricci C, Bellini M, Rahman MM, Melcarne L, Santos J, Lobo B, Bor S, Yapali S, Akyol D, Sapmaz FP, Urun YY, Eskazan T, Celebi A, Kacmaz H, Ebik B, Binicier HC, Bugdayci MS, Yagci MB, Pullukcu H, Kaya BY, Tureyen A, Hatemi I, Koc ES, Sirin G, Caliskan AR, Bengi G, Alis EE, Lukic S, Trajkovska M, Hod K, Dumitrascu D, Pietrangelo A, Corradini E, Simren M, Sjolund J, Tornkvist N, Ghoshal UC, Kolokolnikova O, Colecchia A, Serra J, Maconi G, De Giorgio R, Danese S, Portincasa P, Di Sabatino A, Maggio M, Philippou E, Lee YY, Salvi D, Venturi A, Borghi C, Zoli M, Gionchetti P, Viale P, Stanghellini V, Barbara G, Piacentini A, Shengelia M, Vechorko V, Cardamone C, Rosei CA, Pancetti A, Rettura F, Pedrosa M, Nieto A, Barber C, Henao A, Campoli C, Mijac D, Korac M, Karic U, Markovic A, Najdeski A, Nikolova D, Dimzova M, Lior O, Shinhar N, Perelmutter O, Ringel Y, Sabo CM, Chis A, Bonucchi G, Ismaele Caio GP, Ghirardi C, Marziani B, Rizzello B, Aguilar A, Di Paolo DM, Bonfrate L, Marconi G, Stefano MD, Tagliaferri S, Naves JE, Galli A, Dragoni G, Nedelcu L, Stevanovic M, Nikolovska AV, Capogreco A, Aghemo A, Mauloni PA, Vecchio SD, Rotondo L, Capuani F, Montanari D, Palombo F, Paone C, Mastel G, Fontana C, Bellacosa L, Cogliandro RF
Post COVID-19 irritable bowel syndrome
Gut. 2022 Dec 9:gutjnl-2022-328483
DOI: doi: 10.1136/gutjnl-2022-328483
IF: 31.80

Marasco G, Cremon C, Barbaro MR, Salvi D, Cacciari G, Kagramanova A, Bordin D, Drug V, Miftode E, Fusaroli P, Mohamed SY, Ricci C, Bellini M, Rahman MM, Melcarne L, Santos J, Lobo B, Bor S, Yapali S, Akyol D, Sapmaz FP, Urun YY, Eskazan T, Celebi A, Kacmaz H, Ebik B, Binicier HC, Bugdayci MS, Yagci MB, Pullukcu H, Kaya BY, Tureyen A, Hatemi I, Koc ES, Sirin G, Caliskan AR, Bengi G, Alis EE, Lukic S, Trajkovska M, Hod K, Dumitrascu D, Pietrangelo A, Corradini E, Simren M, Sjolund J, Tornkvist N, Ghoshal UC, Kolokolnikova O, Colecchia A, Serra J, Maconi G, De Giorgio R, Danese S, Portincasa P, Di Stefano M, Maggio M, Philippou E, Lee YY, Venturi A, Borghi C, Zoli M, Gionchetti P, Viale P, Stanghellini V, Barbara G
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study
Am J Gastroenterol. 2022 Jan 1;117(1):147-157
DOI: doi: 10.14309/ajg.0000000000001541
IF: 12.05

Lesnovska KP, Munch A, Bonderup O, Magro F, Kupcinskas J, Zabana Y, Tontini GE, Munck LK, Guagnozzi D, Latella G, Fernandez-Banares F, Miehlke S, Madisch A, Wildt S, Hjortswang H
The Process of Developing a Disease Activity Index in Microscopic Colitis
J Crohns Colitis. 2022 Mar 14;16(3):452-459
DOI: doi: 10.1093/ecco-jcc/jjab170
IF: 10.02

Salvo-Romero E, Rodino-Janeiro BK, Albert-Bayo M, Lobo B, Santos J, Farre R, Martinez C, Vicario M
Eosinophils in the Gastrointestinal Tract: Key Contributors to Neuro-Immune Crosstalk and Potential Implications in Disorders of Brain-Gut Interaction
Cells. 2022 May 14;11(10). pii: cells11101644
DOI: doi: 10.3390/cells11101644
IF: 7.67

NEUROGASTRO -Neurofisiología y neurofisiopatología digestiva
Principal Investigator: Fernando Azpiroz Vidaur
Agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 108,900€
Period: 01/09/2022 - 01/09/2026

Contribución diferencial del epitelio intestinal a la fisiopatología de la diarrea crónica en el síndrome del intestino irritable y la colitis microscópica. Perfil clínico-biológico para el diagnóstico diferencial.
Principal Investigator: IP: Maria Vicario Perez Collaborators: Beatriz Lobo Alvarez, Merce Albert Bayo, Inés de Torres Ramirez, Ana Maria Gonzalez Castro, Marc Pigrau Pastor, Xavier Serra Ruiz
Agency: Instituto de Salud Carlos III. Referencia: PI19/01643
Funding: 183,920€
Period: 01/01/2020 - 30/06/2024

Identificación de un panel integrado de biomarcadores no invasivos predictivos del diagnóstico de colitis microscópica
Principal Investigator: Danila Guagnozzi
Agency: Instituto de Salud Carlos III. PI17/01443
Funding: 159,720€
Period: 01/01/2018 - 30/06/2022

CFTR down regulation enhances pancreatic carcinogenesis and promotes cancer invasion and metastasis
Principal Investigator: Francesc Xavier Molero Richard
Agency: Cistic Fibrosis Foundation
Funding: 307,328€
Period: 01/05/2022 - 30/04/2023

Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in IRritable bowel syndrome In Europe (DISCOvERIE)
Principal Investigator: Fco Javier Santos Vicente
Agency: EUROPEAN COMMISSION. H2020-SC1-BHC-01-2019
Funding: 1,147,462.49 €
Period: 01/01/2020 - 31/12/2024

Owner of the intellectual property rights of the questionnaire “QUECOMIICAT”
Priority Number: B-390-18 2018
Priority Date: 2018
Applicants: VHIR, Given